N-substituted-azacyclylamines as histamine-3 antagonists

Details N-substituted-azacyclylamines as histamine-3 antagonists N-substituted-azacyclylamines as histamine-3 antagonists

2007-03-14

2010-10-26

Chung, Susannah (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S250000, C548S255000, C548S262200, C548S300100, C548S400000

Reexamination Certificate

active

07820825

ABSTRACT:
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the histamine-3 receptor.

REFERENCES:
patent: 3933829 (1976-01-01), Archibald et al.
patent: 4159331 (1979-06-01), McCall
patent: 4166853 (1979-09-01), McCall
patent: 5294631 (1994-03-01), Franz et al.
patent: 5883096 (1999-03-01), Lowe et al.
patent: 6034093 (2000-03-01), Ewing et al.
patent: 6541499 (2003-04-01), Bastian et al.
patent: 6699873 (2004-03-01), Maguire et al.
patent: 2004/0082779 (2004-04-01), Vos et al.
patent: 2005/0256102 (2005-11-01), Claiborne et al.
patent: 2006/0014733 (2006-01-01), Howard, Jr. et al.
patent: 2006/0089496 (2006-04-01), Lam et al.
patent: 2006/0166960 (2006-07-01), Aslanian et al.
patent: 2007/0004713 (2007-01-01), Barlaam et al.
patent: 2007/0032475 (2007-02-01), Ye et al.
patent: 2007/0270440 (2007-11-01), Cole et al.
patent: 2008/0119458 (2008-05-01), Solvibile et al.
patent: 1416872 (1975-12-01), None
patent: WO 94/22826 (1994-10-01), None
patent: WO 98/48800 (1998-11-01), None
patent: WO 01/42224 (2001-06-01), None
patent: WO 01/74773 (2001-10-01), None
patent: WO 03/004467 (2003-01-01), None
patent: WO 03/082272 (2003-10-01), None
patent: WO 2004/081011 (2004-09-01), None
patent: WO 2005/115977 (2005-12-01), None
patent: WO 2006/011042 (2006-02-01), None
patent: WO 2006/019833 (2006-02-01), None
patent: WO 2006/023462 (2006-03-01), None
patent: WO 2006/028269 (2006-03-01), None
patent: WO 2006/040281 (2006-04-01), None
patent: WO 2007/107539 (2007-09-01), None
patent: WO 2007/108936 (2007-09-01), None
patent: WO 2007/115933 (2007-10-01), None
patent: WO 2008/045371 (2008-04-01), None
Patani et al., Chem Rev, 1996, vol. 96 (8), pp. 3147-3176, especially p. 3148.
Blandina, P. et al., “Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats”, Br J Pharmacol. Dec. 1996;119(8):1656-64.
Database Chemcats [Online] chemical abstract service. Ambinter Stock Screening Collection; Feb. 13, 2008.
Esbenshade et al., “Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders”. Mol Interv. Apr. 2006;6(2):77-88.
Fox, G. B. et al., “Effects of histamine H(3) receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup”, Behav Brain Res. Apr. 1, 2002;131(1-2):151-61.
Hancock et al., Perspectives on cognitive domains, H3 receptor ligands and neurological disease. Expert Opin Investig Drugs. Oct. 2004;13(10):1237-48.
Koh et al. “Conformational and structural features determining in vitro antimalarial activity in some indolo 3, 2-couinolines, anilinoquinolines and tetrahydroindolo3, 2-dbenzazepines”. European Journal of Medicinal Chemistry. vol. 29, No. 2, 1994, p. 107-113.
Komater, V.A., et al., “H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization”, Psychopharmacology (Berl). Jun. 2003;167(4):363-72.
Meguro, K. et al., “Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice”, Pharmacol Biochem Behav. Mar. 1995;50(3):321-5.
Miyazaki, S. et al., “Effects of clobenpropit (VUF-9153), a histamine H3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice”, Life Sci. 1997;61(4):355-61.
PCT International Search Report, Written Opinion of the International Searching Authority for corresponding PCT/US2007/005776, International filing date Mar. 8, 2007.
Prast, H. et al., “Histaminergic neurons facilitate social memory in rats”, Brain Res. Sep. 23, 1996;734(1-2):316-8.

Affiliated with

Also associated with

Rating

N-substituted-azacyclylamines as histamine-3 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-substituted-azacyclylamines as histamine-3 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted-azacyclylamines as histamine-3 antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4218334